Quest Diagnostics is the world's leading provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The Company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its extensive medical and scientific staff, cancer diagnostics, and anatomic pathology services.

Quest Diagnostics's wide range of products and services benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies, and employers.

TypePublic
HQMadison, US
Founded1967
Size (employees)45,000 (est)+5%
Websitequestdiagnostics.com
Quest Diagnostics was founded in 1967 and is headquartered in Madison, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Quest Diagnostics

Stephen H. Rusckowski

Stephen H. Rusckowski

Chairman, President and Chief Executive Officer

Quest Diagnostics Office Locations

Quest Diagnostics has offices in Barceloneta, Bayamón, Guaynabo, San Juan and in 6 other locations
Madison, US (HQ)
Giralda Farms
Secaucus, US
500 Plaza Dr
Barceloneta, PR
PR-2
Bayamón, PR
Av. Main
Caguas, PR
5 Av. Luis Muñoz Marín
Caguas, PR
5 Calle Padial
Show all (12)
Report incorrect company information

Quest Diagnostics Financials and Metrics

Quest Diagnostics Revenue

Embed Graph
Quest Diagnostics's revenue was reported to be $7.71 b in FY, 2017 which is a 2.6% increase from the previous period.
USD

Revenue (Q2, 2018)

3.8 b

Gross profit (Q2, 2018)

1.3 b

Gross profit margin (Q2, 2018), %

35.1%

Net income (Q2, 2018)

422 m

EBIT (Q2, 2018)

577 m

Market capitalization (21-Sep-2018)

14.7 b

Closing stock price (21-Sep-2018)

107.6

Cash (30-Jun-2018)

132 m

EV

18.3 b
Quest Diagnostics's current market capitalization is $14.7 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

7.1 b7.4 b7.5 b7.5 b7.7 b

Revenue growth, %

4%1%0%3%

Cost of goods sold

4.3 b4.6 b4.7 b4.6 b4.7 b

Gross profit

2.8 b2.8 b2.8 b2.9 b3 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

1.8 b1.7 b1.9 b1.9 b1.8 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b3.8 b

Cost of goods sold

1.1 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b2.5 b

Gross profit

698.6 m645 m728 m726 m676 m743 m718 m719 m751 m728 m734 m773 m741 m658 m1.3 b

Gross profit Margin, %

39%37%38%38%37%39%38%39%39%39%39%40%38%35%35%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

187 m192 m133 m359 m137 m

Accounts Receivable

926 m924 m

Prepaid Expenses

155 m150 m

Inventories

91 m110 m84 m82 m95 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

158.3 m144 m144 m170 m974 m150 m123 m128 m283 m406 m367 m314 m350 m124 m132 m

Inventories

85.2 m99 m109 m111 m106 m109 m86 m82 m80 m82 m77 m83 m100 m94 m91 m

Current Assets

1.4 b1.5 b1.5 b1.6 b2.4 b1.5 b1.6 b1.5 b1.5 b1.6 b1.6 b1.5 b1.5 b1.4 b1.4 b

PP&E

749.4 m851 m884 m888 m902 m906 m886 m925 m937 m952 m1 b1 b1.1 b1.2 b1.2 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

883 m592 m753 m696 m824 m

Depreciation and Amortization

304 m249 m270 m

Accounts Payable

(21 m)68 m(24 m)56 m(8 m)

Cash From Operating Activities

652 m938 m821 m1.1 b1.2 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

732.1 m111 m253 m392 m70 m199 m553 m114 m324 m529 m175 m382 m557 m189 m422 m

Depreciation and Amortization

211 m75 m156 m235 m78 m153 m230 m62 m123 m186 m62 m128 m197 m74 m151 m

Accounts Payable

(76.8 m)(86 m)(39 m)20 m(120 m)(49 m)(41 m)(77 m)23 m43 m(95 m)(93 m)(3 m)(68 m)(64 m)

Cash From Operating Activities

441.6 m84 m364 m635 m52 m327 m539 m143 m464 m765 m196 m490 m852 m180 m503 m
USDY, 2018

EV/EBIT

31.7 x

EV/CFO

36.4 x

EV/FCF

52 x

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2 x
Show all financial metrics

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Show all operating metrics

Quest Diagnostics Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
California Laboratory AssociatesOctober 30, 2017
Cleveland HeartLabOctober 18, 2017
Cape Cod Healthcare - BusinessJune 28, 2017
ClearPoint DiagnosticJune 12, 2017
Med fusionJune 12, 2017
PeaceHealth LaboratoriesFebruary 15, 2017

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other

Report incorrect company information

Quest Diagnostics Online and Social Media Presence

Embed Graph
Report incorrect company information

Quest Diagnostics News and Updates

Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec

SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Sept. 25, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today...

Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics

SECAUCUS, N.J. and WOBURN, Mass., Sept. 24, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services. About 10 percent of...

Revenue Cycle Management (RCM) Beating Market by Excellent Revenue growth by 2025 | Athenahealth, Cerner Corporation,Eclinicalworks, Mckesson, Quest Diagnostics

Scope of the Report:This report studies the Revenue Cycle Management (RCM) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Revenue Cycle Management (RCM) …

Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent

SECAUCUS, N.J., Sept. 6, 2018 /PRNewswire/ -- More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other drugs and dangerous drug combinations, finds a new...

Cognitive Assessment and Training in Healthcare Market In-Depth Analysis including key players Cambridge Cognition Ltd.(UK), Bracket(US), Quest Diagnostics

HTF MI released a new market study on Global Cognitive Assessment and Training in Healthcare Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of...
Show more
Report incorrect company information

Quest Diagnostics Company Life and Culture

Report incorrect company information